NewLife Eco- Pro is a new line of premium, eco-friendly and ergonomic commercial antifatigue floor mats designed specifically to benefit a workforce that stands. NewLife Eco-Pro is the industry’s first integral skin polyurethane mat made with Bio-Foam, a plant-based renewable resource. According to new research, the use of NewLife Eco-Pro mats can positively impact the health of people who stand for long periods. Texas A&M University’s System Health Science Center, conducted an independent research study that evaluated the ergonomics of industrial anti-fatigue floor mats. The study concluded that NewLife Eco-Pro is superior at reducing spinal compression and maintaining flexibility in workers who spend time standing as compared to traditional anti-fatigue mats. NewLife Eco-Pro mats not only provide much needed relief to employees who stand, but their use can reduce injury and time away from work while minimizing employer’s exposure to health-related claims. NewLife Eco-Pro mats maintain their quality and appearance, and won’t become a tripping hazard, disintegrate or develop an undesirable smell, all of which are typical issues with traditional commercial anti-fatigue mats. The mats also have anti-microbial properties and will not absorb water. At three quarters of an inch thick, New Life Eco-Pro mats are puncture- and stain-resistant, and maintain resilience and optimal comfort over time. Certified by the National Floor Safety Institute (NFSI) for its high-traction bottom surface, NewLife ensures the highest level of slip resistance compared to other mats currently on the market.
Read more

SonoSite’s portable ultrasound machines are intuitive, durable, and backed by a 5-year warranty. Our machines undergo rigorous durability testing, hours of quality assurance, and are designed with clinicians from the ground up. As a company, we’re committed to spreading point-of-care ultrasound education through online webinars, in-person education and our mobile app.

• We make our ultrasound equipment tough because you need to focus on providing care to your patient, not on whether your machine needs repair.
•  We make our machines intuitive because the last thing you need is an ultrasound machine you can’t figure out how to use.
• We provide access to educational resources because we’re committed to helping you improve patient outcomes. 
• Our machines are ready to go when you are. And should a problem arise, your ultrasound machine is backed by a 5-year warranty

Read more

Carestream will showcase its CARESTREAM Touch Prime and Touch Prime XE Ultrasound Systems at the 28th Euroson Congress of the EFSUMB taking place in Leipzig, Germany from 26 to 29 October. Both Touch Prime and Touch Prime XE systems provide exceptional image quality. They also streamline measurements to expedite clinician access to critical imaging information while boosting staff productivity. Advanced computing power and the company’s SynTek architecture deliver a simultaneous increase in frame rate, improved penetration and uniform focus throughout the field of view. Touch Prime and Touch Prime XE systems offer Smart Flow, Smart Flow Assist and Smart Select technology designed to further enhance workflow.
Smart Flow imaging technology eliminates the transducer angle limitations of ordinary Doppler ultrasound, and its proprietary Smart Flow method can visualize and measure velocity even when blood flow is perpendicular to the acoustic beam. The resulting measurements are angle independent-and therefore less prone to measurement error. The new ultrasound systems also visualize blood flow in all directions including axial and transverse, which provides more comprehensive information about hemodynamics to assist with diagnostic decisions. The benefits offered by this advanced ultrasound imaging technology can play a vital role in accurately assessing clinical applications such as evaluation of hemodialysis vascular access (AV fistulas and grafts) and quantification of complex flow patterns in the presence of stenosis. Colour coding and arrows automatically display information from Smart Flow technology on the Touch Prime Ultrasound platform. The length of the arrow, in addition to the colour, indicates magnitude. The orientation of the arrow indicates flow direction. Ordinary colour and spectral Doppler ultrasound only measure velocity of flow components toward or away from a transducer.
Smart Flow Assist automatically determines the highest area of flow, and places and adjusts sample size as well as angle corrections. This reduces the number of key strokes for velocity and volume measurements. Integrated one-touch transducer activation and a mode-programmable Smart Select button on the transducers allow a sonographer to reduce key strokes and improve productivity. A single touch of a button allows the user to activate the transducer as well as program two additional functions from a list of 16 commonly used functions.
Carestream’s advanced SynTek Architecture simultaneously provides enhanced spatial detail with increased frame rates for improved visualization of moving structures, while optimizing image formation to reduce noise and artifacts. Imaging and Doppler improvements allow for more consistent visualization of subtle tissue contrast differences and can increase the ability to see small structures. These systems also deliver uniform lateral resolution over the entire depth and deeper penetration for imaging of the abdomen and other areas.
Carestream offers specialized transducers for vascular imaging as well as radiology, OB/GYN and musculoskeletal imaging. A direct transducer interface to the ultrasound processing board delivers lower noise and higher image quality, and four transducers can be connected simultaneously to any of the system’s four ports.
The Touch Prime XE is capable of frame rates in excess of 100Hz while maintaining enhanced imaging detail, and includes optional features such as a DICOM package, barcode and RFID badge readers. Wireless connectivity provides rapid image transfers to PACS, RIS and other systems. An integrated gel warmer delivers added convenience and patient comfort.
The Touch Ultrasound platform’s design is based upon recommendations by sonographers and ultrasound professionals across the world. These systems have earned praise for a sealed, all-touch control panel that combines the speed and flexibility of a soft user interface with the tactile feedback of traditional keys. Etched marking for primary controls equips the user to easily locate frequently used functions without looking away from the image display monitor.
Read more

The Affirm prone biopsy system is the first dedicated prone biopsy system capable of both stereotactic and tomosynthesis-guided breast biopsies. The Affirm prone biopsy system is CE marked and pending 510k clearance in the U.S. The new system complements Hologic’s Selenia Dimensions mammography system and Affirm upright biopsy system to ensure that facilities have all the options necessary to provide minimally invasive breast biopsy to their patients. The Affirm prone system provides enhanced biopsy performance over existing prone systems with exceptional biopsy imaging capabilities using the same detector technology as the Hologic tomosynthesis mammography system; a streamlined workflow designed to make the system fast and easy to use; access to challenging lesion locations with a fully integrated C-arm. The C-arm allows a full 360° access to the breast with both standard and lateral needle approaches—without requiring additional accessory attachments.
Read more

ZedScan is a portable, handheld device that uses patented Electrical Impedance Spectroscopy (EIS) to detect the development of pre-cancerous abnormalities of the cervix, known as cervical intraepithelial neoplasia (CIN). The innovative system not only removes subjectivity and increases accuracy, but it also helps clinicians manage growing colposcopy referrals generated by the introduction of primary HPV testing. In a recent review of over 1500 women referred to an NHS colposcopy clinic, the adoption of ZedScan resulted in a significant increase in disease detection and improvements in clinical performance. The patient case study revealed a 13% increase in detection of high-grade disease (HGCIN) across all patients, with 50% increase reported in women with low-grade cytology. In 92% of these cases, disease was confirmed with a single biopsy. If rolled out across the UK, this would equate to an additional 200 women being identified with HGCIN every week, or approximately 10,000 women each year who can therefore be diagnosed and treated much earlier. Thus preventing disease from developing. Performance was not impacted by the hrHPV genotype with increased detection in both HPV16 and non 16 hrHPV positive women. Cervical cancer is the 7th most common disease globally, and the third most prevalent in woman. The disease is caused by the persistent high-risk human papillomavirus (HPV) infection, which triggers changes in the cervical cells. Although colposcopy is an important method in detecting cervical cancer, in practice, the procedure has not drastically changed over the last 90 years, and diagnosis depends on the subjective assessment of visual indicators by the clinician. An objective assessment will help clinicians to better manage patients and help avoid unnecessary biopsies, treatments and repeat follow-up appointments.

Read more